Anti-IL-18R antibody (Reistone Bio)

抗IL-18R抗体(瑞石生物)

Report date: 2025/04/01 15:10:15

Base Information

Drug NameAnti-IL-18R antibody (Reistone Bio)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Interleukin 18 receptor
TargetsInterleukin 18 receptor
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesReistone Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A